Trade CNTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Context Therapeutics Inc. (CNTX) is trading at US$0.37, down 3.99% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$45.95M. Over the past 52 weeks, CNTX has traded between US$0.34 and US$3.62. On Syfe you can trade CNTX with $0 commission and add it to your watchlist.
| Previous close | US$0.38 |
|---|---|
| Market cap | US$45.95M |
| 52-week range | US$0.34 – US$3.62 |
| Volume | 1.12M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Context Therapeutics Inc.
Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. The firm's robust clinical program for candidate onapristone extended release (ONA-XR) comprises three Phase 2 clinical trials and one Phase 1b/2 clinical trial in hormone-driven breast, ovarian and endometrial cancer, as well as two Phase 0 biomarker pharmacodynamic trials in breast cancer. Its ONA-XR is a novel, first-in-class small molecule under development as a complete antagonist of the progesterone receptor, a key unchecked mechanism in hormone-driven women?s cancers. The company was founded by Martin Lehr and Felix Kim in April 2015 and is headquartered in Philadelphia, PA.
Year: 2021
Context Therapeutics Joins Russell 2000, Russell 3000 Indexes
Jul 6, 8:17 PM · MT Newswires
Context Therapeutics to Proceed With Next Development Phase of CTIM-76 in Ovarian Cancer
Jun 15, 11:16 AM · MT Newswires
Context Therapeutics Secures Full Rights to CT-202 Under Revised BioAtla Deal
May 18, 11:29 AM · MT Newswires
Context Therapeutics Says CTIM-76 Antibody Granted Fast Track Designation by FDA
Apr 2, 12:07 PM · MT Newswires
Context Therapeutics Inc. (CNTX) stock is trading at US$0.37, -3.99% from the previous close of US$0.38.
The market cap for Context Therapeutics Inc. (CNTX) stock is approximately US$45.95M.
The 52-week high for Context Therapeutics Inc. (CNTX) stock is US$3.62.
The 52-week low for Context Therapeutics Inc. (CNTX) stock is US$0.34.
Context Therapeutics Inc. (CNTX) does not currently pay a dividend.
Stay on top of CNTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
